¹Ù·Î°¡±â ¸Þ´º

¹Ù·Î°¡±â ¸Þ´º º»¹®³»¿ë ¹Ù·Î°¡±â ¸ÞÀθ޴º ¹Ù·Î°¡±â

ÁÖ¿ä¾È³»

HOME »çÀÌÆ®¸Ê

FONT SIZE

ÆùƮũ±â Å°¿ò 100% 110% 120% 130% 140% ÆùƮũ±â ÁÙÀÓ
¸Þ´ºº¸±â
 
Á¦¸ñ
9/26 ¹ßÇ¥ ³í¹®ÀÔ´Ï´Ù.
ÀÛ¼ºÀÏ
2020-09-23
Á¶È¸¼ö
264


¾È³çÇϼ¼¿ä.
À̹ø ÁÖ ¹ßÇ¥ÀÚ ÀÎȯÀÔ´Ï´Ù. 

Á¦°¡ À̹ø ÁÖ ¹ßÇ¥ÇÒ ³í¹®Àº ÀÛ³â 9¿ù¿¡ Immunity¿¡ publishµÈ ³í¹®ÀÎ 'Differential Activation of the Trans
cription Factor IRF1 Underlies the Distinct Immune Responses Elicited by Type I and Type III Interferons'ÀÔ´Ï´Ù.

ÀÌ ³í¹®¿¡¼­´Â Àü»çÀÎÀÚÀÎ IRF1ÀÇ activation Â÷ÀÌ¿¡ µû¶ó type I°ú type III interferon signaling pathway¿¡ ÀÇÇÑ À¯ÀüÀÚ ¹ßÇöÀÌ ¾î¶»°Ô Â÷ÀÌ°¡ ³ª°Ô µÇ¸ç, ÀÌ·¯ÇÑ Â÷ÀÌÁ¡¿¡ ÀÇÇØ ÀÌ µÎ typeÀÇ interferonµéÀÌ viral infection »óȲ¿¡¼­ ¾î¶»°Ô inflammationÀ» ÅëÇÑ ¹æ¾îÀÛ¿ë ¹× tissue damage¸¦ ÃÖ¼ÒÈ­Çϸç antiviral effect¸¦ ³ªÅ¸³»´Â Áö¿¡ ´ëÇØ ¼³¸íÇÏ°í ÀÖ½À´Ï´Ù.

ÀÌ ³í¹®À» ¼±Á¤ÇÑ ÀÌÀ¯´Â Á¦°¡ viral infection¿¡ °ü½ÉÀÌ Àִµ¥, viral infection¿¡ ´ëÀÀÇÒ ¼ö ÀÖ´Â °ÍÀ¸·Î Àß ¾Ë·ÁÁø ½Ã½ºÅÛÀÎ interferon system¿¡ ´ëÇØ °øºÎ¸¦ Çغ¸°íÀÚ ¼±Á¤ÇÏ¿´½À´Ï´Ù.

¶ÇÇÑ ÃÖ±Ù tissue repair ¹× antiviral effect¿¡ À־ type III interferonÀÇ ¿ªÇÒ¿¡ ´ëÇÑ ¿¬±¸°¡ ÁøÇàµÇ°í Àִµ¥, ÀÌ·¯ÇÑ type III interferon¿¡ ´ëÇؼ­µµ °ü½ÉÀ» °¡Áö°í ´õ °øºÎ¸¦ ÇÏ°íÀÚ ¼±Á¤ÇÏ¿´½À´Ï´Ù.


°Ç°­ À¯ÀÇÇÏ½Ã°í ¿­½ÉÈ÷ ÁغñÇؼ­ Åä¿äÀÏ¿¡ ºË°Ú½À´Ï´Ù.
°¨»çÇÕ´Ï´Ù.

ÃÖÀÎȯ ¿Ã¸²

https://www.sciencedirect.com/science/article/pii/S1074761319303231
÷ºÎÆÄÀÏ:
÷ºÎÆÄÀÏÀÌ ¾ø½À´Ï´Ù.
´ÙÀ½±Û
9/26 ¹ßÇ¥³í¹® ÀÔ´Ï´Ù
/ °ü¸®ÀÚ
¾È³çÇϼ¼¿ä ³»ÀÏ Á¦°¡ ¹ßÇ¥ÇÒ ³í¹®Àº ¿ÃÇØ Scientific Reports¿¡ ³ª¿Â ³í¹®À¸·Î, Vitamin C¿¡ ÀÇÇؼ­ human gd T cell¿¡¼­ foxp3 ¹ßÇöÀÌ À¯µµµÊÀ¸·Î½á regulatory functionÀ» °¡Áö°Ô µÇ°í ÀÌ´Â foxp3 gene¿¡¼­ÀÇ epigenetic modification¿¡ ÀÇÇØ ¹ß»ýÇÑ´Ù´Â °ÍÀ» È®ÀÎÇÑ ³í¹®ÀÔ´Ï´Ù. [Vitamin C supports con..
ÀÌÀü±Û
9/26 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
/ °ü¸®ÀÚ
¾È³çÇϼ¼¿ä. À̹øÁÖ ¹ßÇ¥ÀÚ ÀÌÁ¤Ã¶ÀÔ´Ï´Ù. Á¦°¡ À̹øÁÖ ¹ßÇ¥ÇÒ ³í¹®Àº 2020³â 5¿ù¿¡ Cell Reports¿¡ ÃâÆÇµÈ "Suppression of Inflammasome Activation by IRF8 and IRF4 in cDCs is Critical for T cell priming" ÀÔ´Ï´Ù. ÀÌ ³í¹®¿¡¼­´Â cDCÀÇ ºÐÈ­¿¡ ÀÛ¿ëÇÏ´Â Àü»çÀÎÀÚÀÎ IRF4¿Í IRF8ÀÌ Inflammasome ac..